Greenwood Capital Associates’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-728
| Closed | -$45K | – | 209 |
|
|
2020
Q2 | $45K | Hold |
728
| – | – | 0.01% | 183 |
|
|
2020
Q1 | $39K | Sell |
728
-8,985
| -93% | -$481K | 0.01% | 152 |
|
|
2019
Q4 | $1.18M | Buy |
9,713
+696
| +8% | +$84.2K | 0.25% | 77 |
|
|
2019
Q3 | $1.64M | Sell |
9,017
-1,343
| -13% | -$244K | 0.4% | 65 |
|
|
2019
Q2 | $1.35M | Buy |
10,360
+4,783
| +86% | +$622K | 0.34% | 65 |
|
|
2019
Q1 | $1.36M | Buy |
5,577
+119
| +2% | +$29K | 0.35% | 63 |
|
|
2018
Q4 | $1.04M | Buy |
5,458
+2,178
| +66% | +$415K | 0.27% | 69 |
|
|
2018
Q3 | $1.08M | Buy |
3,280
+1,547
| +89% | +$507K | 0.23% | 74 |
|
|
2018
Q2 | $541K | Buy |
1,733
+177
| +11% | +$55.3K | 0.12% | 92 |
|
|
2018
Q1 | $379K | Buy |
1,556
+71
| +5% | +$17.3K | 0.09% | 122 |
|
|
2017
Q4 | $449K | Buy |
1,485
+306
| +26% | +$92.5K | 0.1% | 121 |
|
|
2017
Q3 | $312K | Buy |
1,179
+69
| +6% | +$18.3K | 0.08% | 144 |
|
|
2017
Q2 | $292K | Buy |
1,110
+704
| +173% | +$185K | 0.08% | 148 |
|
|
2017
Q1 | $146K | Buy |
406
+60
| +17% | +$21.6K | 0.04% | 204 |
|
|
2016
Q4 | $100K | Buy |
+346
| New | +$100K | 0.03% | 185 |
|